This observation opened the possibility that the growth delay observed for grafts in Ccrl2-deficient mice might be linked to the exclusive expression of CCRL2 by the tumor cells, resulting in a local concentration of the available bioactive chemerin and enabling chemerin to display its anti-tumoral properties through CMKLR1-expressing cells. Here, CMKLR1 is linked to neoplasm.